[Hyperprolactinemia secondary to hypotensive treatment with verapamil].
M
M
Ortega Calvo
V
V
Macías Pérez
M N
MN
Merino Kolly
J
J
Torelló Iserte
D000328:Adult; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects*; D014700:Verapamil / Q000009:adverse effects*
D014665:Vasodilator Agents; D014700:Verapamil